Our Team

Our Team

We are a partnership across industry, academia, healthcare, government, patients and the public committed to rapidly discover, implement and commercialize ‘omics-based biomarker tests that address unmet medical needs.

Our Programs

Our Programs

Our biomarker programs harness the power of clinical, molecular and computational science to develop biomarker tests to better predict, diagnose, manage and treat a range of disease indications.

Our Services

Our Services

We offer flexible partnering options that provide organizations around the world with support in artificial intelligence, ‘-omics science and various biomarker workflows that will expedite diagnostic and drug development efforts.

COVID19 Update

We are committed to supporting the healthcare and research community during the COVID19 crisis through redeployment of our resources.

Click HERE to read more about how we can help.

Latest Publication

2025 Yang C, Tebbutt SJ. Long-Term Prognosis of Patients With Myocarditis. JAMA. 2025 Jan 27. doi: 10.1001/jama.2024.25763 2024 Yang C, Shannon CP, Tebbutt SJ. Unravelling long COVID: insights from proteomics and considerations for comprehensive understanding. EBioMedicine. 2024 Mar;101:105023. doi: 10.1016/j.ebiom.2024.105023 Yang C,

Read more